Public Health Science scientists are focused on finding creative and innovative ways to learn about the causes of cancer, determine how it can be detected early or prevented, establish new methodologies to design and assess biomedical research, and create computational models to address biological questions.
We are identifying strategies to reduce the incidence of and mortality from cancer and other diseases. Their research includes observational studies and intervention trials to evaluate strategies for reducing the risk of cancers of the breast, colon, prostate, ovary, cervix, mouth, esophagus and lung, among others. Emerging population research trends include cancer risk factors; personalized medicine, screening and prevention; health disparities; the unmet needs of cancer survivors; and health care costs.
Coordinating centers based in the division serve to expand research opportunities, including incorporating population science expertise with outcomes/survivorship research, expanding expertise to other cancers and building partnerships with outside organizations to extend access to populations and data. Our scientists are active in interdivisional programs and have also played key leadership roles in the programs for breast cancer, prostate cancer, ovary cancer and gastrointestinal cancer.
The division is funded primarily through investigator-led grants and contracts.
Key to the conduct of population-based studies is the ability to engage participants and expertly collect research data from them throughout their participation in a study. We facilitate this by providing services through the Nutrition Assessment and Prevention Center shared resources. Both are open to Fred Hutch and external researchers.
We collaborate and coordinate with research programs both within and outside Fred Hutch. We develop new methods for a range of studies and build models of carcinogenesis and other biological processes.
We use an interdisciplinary approach to evaluate the causes, detection and control of cancer. Through a variety of studies, we conduct research in cancer screening, early detection, risk prediction, prevention strategies and survivorship.
Our researchers develop computational methods and tools to address biological questions. We have expertise in transcription/translation control, adaptive-immune system dynamics and phylogenetics.
Our team studies factors that increase the risk and recurrence of cancer and other diseases. Our research includes identifying prevention behaviors, minimizing occurrence and increasing quality of life for diagnosed patients.
We discover and translate molecular and epidemiological findings for use in both the lab and the clinic.